Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

54.50
Delayed Data
As of 1:46pm ET
 +0.76 / +1.41%
Today’s Change
37.26
Today|||52-Week Range
65.51
+13.95%
Year-to-Date
No recent news for Ionis Pharmaceuticals Inc.

Today’s Trading

Previous close53.74
Today’s open54.03
Day’s range53.43 - 54.83
Volume243,352
Average volume (3 months)1,327,253
Market cap$6.7B
Dividend yield--
Data as of 1:46pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+2.70%
Earnings growth (this year)+83.53%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+22.18%
P/E ratio237.1
Price/Sales16.69
Price/Book65.65

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-1.69-1.34%
TSROTESARO Inc+2.03+2.43%
RDYDr.Reddy's Laborator...+1.52+4.31%
GRFSGrifols SA0.000.00%
Data as of 2:02pm ET, 11/21/2017

Financials

Next reporting dateMarch 2, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$346.6M
Annual profit (last year)-$86.6M
Net profit margin-24.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Inside Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts